GEORGE R BLUMENSCHEIN to Neovascularization, Pathologic
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Neovascularization, Pathologic.
Connection Strength
0.094
-
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy. J Thorac Oncol. 2008 Jun; 3(6 Suppl 2):S107-12.
Score: 0.047
-
Sorafenib in lung cancer: clinical developments and future directions. J Thorac Oncol. 2008 Jun; 3(6 Suppl 2):S124-7.
Score: 0.047